FDA Approves First Non-Antipsychotic Drug for Alzheimer’s Agitation
The FDA expanded the indication for dextromethorphan hydrobromide and bupropion hydrochloride (Auvelity) extended-release tablets to treat agitation associated with Alzheimer's ...
Novel Pulsed Field Ablation System Turns to High-Energy, Ultra-Short Zaps
The future of pulsed field ablation (PFA) technology could go in the direction of high-voltage nanosecond energy bursts, according to ...
US Court Blocks Mail-order Access to Abortion Drugs, for Now
A U.S. appeals court on Friday temporarily blocked a federal rule allowing the abortion drug mifepristone to be dispensed through ...
Study Examines if Prenatal Exposure to Sedatives Is Linked to Psych Disorders
Prenatal exposure to benzodiazepines or Z-hypnotics was not associated with an increased risk of psychiatric or neurodevelopmental disorders in children ...
FDA OKs Daraxonrasib Pancreatic Cancer Preapproval Access
FDA authorizes an expanded access treatment protocol after the oral RAS(ON) inhibitor doubled survival for metastatic patients in a phase ...
Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer
Approval was based on findings from the phase 3 VERITAC-2 trial showing significantly improved PFS for patients with ESR1-mutated disease. ...
As RFK Jr. Downplays Rabies, CDC Staff Tells Docs It’s a Daily Threat
Just a week after Health Secretary Robert F. Kennedy Jr. downplayed rabies during a Senate hearing based on the few ...
Which Former NIH Official Was Indicted?
The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage ...
In Race to the First Psychedelic Approval, Who’s Leading?
A new FDA regulatory pathway could accelerate approval of psychedelic therapies for resistant depression and PTSD, and experts speculate that ...
RCP Warns on Specialists’ Place in Neighbourhood NHS
A Royal College of Physicians survey found nearly half of specialist doctors are unsure how they will fit into neighbourhood ...
FDA Opens Early Access to Novel Pancreatic Cancer Drug Generating Buzz
The FDA has given the green light to an expanded access program (EAP) for the investigational pancreatic cancer drug daraxonrasib. ...
Real-Time Trial Review Needs a Response Plan, Not Just a Data Feed
When the FDA announced recently that two drug companies had begun streaming clinical trial data to agency reviewers in real ...
New Staging Paradigm Proposed for Advanced cSCC
Using a more pragmatic classification system than the current standard provided clearer discrimination between disease progression and death, a study ...
First-in-Class Vepdegestrant Approved in Advanced Breast Cancer
The FDA approved oral vepdegestrant (Veppanu) for adults with advanced or metastatic estrogen receptor (ER)-positive/HER2-negative breast cancer, the agency announced ...
Brain Changes Linked to Ultraprocessed Foods, Even in Otherwise Healthy Diets
A 10% increase in ultraprocessed food intake was tied to lower attention scores and greater dementia risk in a cross-sectional ...
Sirolimus-Eluting Balloon Shows Promise for Stent Restenosis
A sirolimus eluting balloon performs similarly to a usual care strategy for repeat coronary in stent restenosis at 1 year, ...
Hereditary Angioedema: Epidemiology and Prevalence
Hereditary angioedema (HAE) is a rare autosomal dominant genetic disorder related to low levels of C1 inhibitor, which lead to ...
Hereditary Angioedema Prophylaxis: Persistence and Adherence
Advances in hereditary angioedema attack prophylaxis have provided more options for patients than ever before, with multiple agents available for ...
‘Cyborg’ Islet Cells and Potential New Diabetes Therapies
Researchers combined electronic sensors with human islet cells to create living ‘cyborg’ organoids transmitting troves of previously unseen data on ...
2026 will be the hottest year on record, leading scientist predicts
2026 has already seen extensive wildfires in Patagonia, Argentina, linked to extreme weatherTOMAS CUESTA / AFP via Getty Images A ...
